StudyManager Expands into China

Friday, October 9, 2009

StudyManager, a developer of integrated clinical trial management software (CTMS) and electronic data capture (EDC) solutions, recently expanded operations into China, resulting in sales of its sponsor edition product to two separate Chinese CROs.

[Read More]

WuXi Revenues Up 87% in 2008

Thursday, March 26, 2009

Chinese contract research organization (CRO) WuXi Pharmatech reported an 87% increase in 2008 revenues compared with 2007, with net revenues for continuing operations of $253.5 million. Fourth-quarter 2008 net revenues from continuing operations increased 74% to $64.4 million compared with fourth quarter 2007. The CRO’s non-GAAP net income for 2008 was $58.3 million, up 31% from $44.6 million in 2007.

[Read More]

AstraZeneca Bets More Chips On China

Wednesday, June 28, 2006

AstraZeneca is investing $100 million more in China over the next three years to build the AstraZeneca Innovation Centre China, an R&D facility to study the benefits of new drugs to Chinese patients. Already one of the most heavily invested in China among big pharma companies, AstraZeneca is further distinguishing itself as the leader there with this new commitment.

[Read More]